Insulet | PODD - Trade Debtors



Insulet reported $444.4M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Abbott USD 10.23B 562M Jun/2025
Align Technology USD 1.12B 54.23M Jun/2025
AtriCure USD 66M 2.68M Jun/2025
Avanos Medical USD 110.2M 5.4M Jun/2025
Baxter International USD 1.65B 84M Mar/2025
Becton, Dickinson and Co. USD 2.94B 86M Jun/2025
Boston Scientific USD 2.69B 135M Mar/2025
Cardinal Health USD 13.24B 576M Jun/2025
Cooper Companies USD 792.3M 11.4M Jul/2025
Dexcom USD 1.38B 207.1M Jun/2025
Edwards Lifesciences USD 751.9M 24.5M Mar/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Globus Medical USD 660.12M 122.01M Jun/2025
ICU Medical USD 189.53M 10.19M Jun/2025
Insulet USD 444.4M 42.1M Jun/2025
Integra LifeSciences USD 284.51M 32.06M Jun/2025
J&J USD 16.02B 1.18B Mar/2025
Masimo USD 87.7M 235.1M Jun/2025
Medtronic USD 6.52B 400M Apr/2025
Merit Medical Systems USD 224.24M 7.49M Jun/2025
Roche Holding CHF 13.46B 984M Dec/2024
Solventum Corp 1.26B 144M Jun/2025
Stryker USD 3.92B 43M Jun/2025
Tandem Diabetes Care USD 128.44M 1.88M Jun/2025
Teleflex USD 513.81M 49.29M Jun/2025
West Pharmaceutical Services USD 582.4M 38.8M Jun/2025
Zimmer Biomet Holdings USD 1.61B 77.9M Jun/2025